Home / Inspections / 1053347

FDA Inspection 1053347 — Pacific Cancer Institute, Inc.

Pacific Cancer Institute, Inc. — FEI 3007855961

The FDA completed an inspection of Pacific Cancer Institute, Inc. on May 1, 2018 in Wailuku, HI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 1, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wailuku, HI (United States)

Facility

Other inspections at this facility

  • 1271576 (NAI Wed May 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 966072 (NAI Thu Apr 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888468 (NAI Wed Jul 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 800411 (NAI Fri Aug 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources